Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats (Q43052110)

13 November 2017

title

Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats (English)

1 reference

13 November 2017

Alireza M Nayebi

1

1 reference

13 November 2017

Siyamak R Rad

2

1 reference

13 November 2017

Mehdi Saberian

3

1 reference

13 November 2017

Saeid Azimzadeh

4

1 reference

13 November 2017

Morteza Samini

5

1 reference

13 November 2017

publication date

1 March 2010

1 reference

13 November 2017

published in

Pharmacological Reports

1 reference

13 November 2017

volume

62

1 reference

13 November 2017

issue

2

1 reference

13 November 2017

page(s)

258-264

1 reference

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Alpha 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

5-Hydroxytryptamine1A receptors are linked to a Gi-adenylate cyclase complex in rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

The basal ganglia: focused selection and inhibition of competing motor programs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Molecular Basis of Buspirone's Anxiolytic Action

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Comparative localization of serotonin1A, 1C, and2 receptor subtype mRNAs in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970264-4

7 January 2021

10.1016/S1734-1140(10)70264-4

Identifiers

DOI

1 reference

13 November 2017

1 reference